In follow up to the May 15, 2026 release of the Implementation Measures for the Measures for Drug Trial Data Protection (药品试验数据保护实施办法), China’s National Medical Products Administration also released an Interpretation of the same. The Interpretation provides more details on the Measures, such as what is test data used to prove the safety, efficacy and quality controllability of drugs and is new clinical trial data protected for conditionally approved drugs.
China’s National Medical Products Administration Releases Implementation Measures for Drug Trial Data Protection – May 30, 2026 Submission Deadline!
May 20, 2026 Update: As pointed out by Fan Li, the Center for Drug Evaluation (CDE) subsequently released a Notice clarifying that the deadline for retroactive protection is 15 working days from the May 15 NMPA release yielding a deadline of June 5, 2026. On May 15, 2026, China’s National Medical Products Administration (NMPA) released the Implementation Measures for Drug Trial Data Protection (药品试验数据保护实施办法), effective May 15, 2026. The Measures provide equal drug trial data protection terms for domestic and foreign-developed drugs. …
China State Council’s 2026 Legislative Work Plan
Update: This article has been corrected to include the correct link the State Council’s Work Plan. Further, Changhao Wei has pointed out that the Trademark Law is listed in the Standing Committee of the National People’s Congress (NPCSC) Legislative Work Plan for 2026. On May 11, 2026, China’s State Council released their 2026 Legislative Work Plan (国务院2026年度立法工作计划). Of note, the Trademark Law is not in the Plan despite the draft released for comment in December 2025. Of interest in the …
Punitive Damages, Plant Varieties, and FRAND: Highlights from China’s 2025 IP Status White Paper
On May 7, 2026, China’s National Intellectual Property Administration (CNIPA) released a white paper entitled “China’s Intellectual Property Protection Status in 2025” (二〇二五年中国知识产权保护状况). The white paper documents developments across judicial protection, administrative enforcement, legislative reform, international cooperation, and public services during the final year of China’s 14th Five-Year Plan period.